Lead Sponsor

Massachusetts General Hospital

Age

25 - 75 years

Sex

ALL

Healthy Volunteers

Yes

•1. Male or female.
•2. 25 to 75 years of age.
•3. Subjects requiring revision total hip replacement.
•4. Subjects who demonstrate the ability to return to MGH for follow-up for the next five years.

•1. Subjects with limited life span.
•2. Subjects with difficulty in comprehending study protocol for any reason.
•3. Subjects with complex disease entities which significantly increase the risks of the surgery such as any major platelet abnormality, hematological disorder, or any other major medical complication which could substantially reduce longevity, put them at further risk due to immunocompromisation or increase the risk of infection.
•4. Female subjects that are pregnant or who may suspect they are pregnant or who plan to become pregnant while participating in this study.
•* A urine HCG will be done in all women of child bearing potential prior to RSA imaging at each follow-up visit. The result will be recorded in the research record.

Related studies

NCT04754087 · Total Hip Arthroplasty, Degenerative Joint Disease of Hip, and more

NCT02096211 · Non-inflammatory Degenerative Joint Disease, Osteoarthritis, and more

NCT03672916 · Avascular Necrosis of Hip, Osteoarthritis, Hip, and more

NCT01765296 · Localized Primary Osteoarthritis of Hip, Localized Primary Osteoarthritis of Knee

NCT04348968 · Degenerative Joint Disease of Hip, Osteoarthritis, Hip, and more

Stability of Revision Total Hip Arthroplasty Implants Using Radiostereometric Analysis